Pediatric Unit, Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), Palermo, Italy.
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):102-104. doi: 10.1111/pai.13346.
In the last few years, we have witnessed an important development in the medical field of both Mobile Health, such as the use of mobile communication devices, and other telemedicine tools in general, in order to support the surveillance of diseases from the moment of the first diagnosis to the therapeutic follow-up. Long before COVID-19, some authors had analyzed various possible evidence-based scenarios and had indicated how the use of telemedicine could prove to be extremely useful in epidemic situations, especially for the management of chronic patients, such as immune-allergic ones, who are notoriously in greater need of regular follow-up; however, as expected, the advent of the COVID-19 pandemic has amplified the differences between various countries, from the point of view of the propensity to use technological solutions in the health sector. The hope is that one positive outcome of the ongoing pandemic is that it will lead to an acceleration, by all the stakeholders involved, of the process of modernization of health care.
在过去的几年中，我们见证了移动医疗领域的重要发展，例如使用移动通信设备，以及其他远程医疗工具，以支持从初次诊断到治疗随访的疾病监测。早在 COVID-19 之前，一些作者就分析了各种可能的基于证据的情况，并指出远程医疗的使用如何在流行病情况下证明是非常有用的，特别是对于慢性患者（如免疫过敏患者）的管理，他们特别需要定期随访；然而，正如预期的那样，COVID-19 大流行的出现放大了各国之间的差异，从卫生部门使用技术解决方案的倾向来看。人们希望，正在进行的大流行的一个积极结果将导致所有相关利益攸关方加速医疗保健的现代化进程。
